Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of rotigotine in early-stage Parkinson's disease completed.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine [Phase 3]
A Phase 3 clinical trial evaluating memantine, an NMDA receptor blocker, for inhibiting α-synuclein cell-to-cell transmission in Parkinson d…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Probiotics-prebiotic Fiber Therapy in Parkinson's Disease Patients With Constipation [Phase 3]
A Phase 3 clinical trial investigating a probiotics-prebiotic fiber therapy for constipation in Parkinson's disease patients has completed.
-
CLINICAL_TRIALS withdrawal · 2020-06-17Clinical Trial Update: Safinamide for Levodopa-induced Dyskinesia (PD-LID) [Phase 3]
Phase 3 clinical trial for safinamide in Parkinson disease with levodopa-induced dyskinesia has been withdrawn.
-
FDA approval · 2020-06-16FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for AZILECT (rasagiline mesylate) from Teva Neuroscience, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease [Phase 2]
A Phase 2 pilot trial evaluating the iron chelator deferiprone in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Transcranial Direct Current Stimulation for Freezing of Gait [NA]
A terminated clinical trial examining transcranial direct current stimulation for freezing of gait in Parkinson's disease; results posted in…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: A Study to Investigate a New Treatment in Patients With Parkinson's Disease [Phase 1, Phase 2]
Clinical trial update for a Parkinson's disease study across Phase 1 and Phase 2, status completed.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease [Phase 1, Phase 2]
Open-label investigation assessing safety and clinical effects of NTCELL in Parkinson's disease across Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Cognitive Rehabilitation for PD [NA]
Completed clinical trial on cognitive rehabilitation for Parkinson's disease; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Evaluation of Intensive Language Therapy [NA]
A completed clinical trial evaluating intensive language therapy for Parkinson's disease with results posted in 2020.
-
FDA approval · 2020-05-21FDA Approved: DUOPA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for DUOPA (carbidopa and levodopa) from AbbVie Inc. The action concerns an update to the approved pr…
-
FDA approval · 2020-05-08FDA Approved: RASAGILINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Rasagiline submitted by Chartwell RX, LLC.
-
FDA approval · 2020-04-24FDA Approved: ONGENTYS — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Ongentys (opicapone) as an add-on therapy to levodopa/carbidopa for adults with Parkinson's disease experiencing motor fluctuat…
-
FDA approval · 2020-04-24FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Electronic-health Application To Measure Outcomes REmotely Clinical Trial [NA]
A completed clinical trial using an electronic health application to measure outcomes remotely in neurodegenerative disease contexts, with r…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Ambroxol in Disease Modification in Parkinson Disease [Phase 2]
A Phase 2 clinical trial evaluating ambroxol for disease modification in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Phase I, KM-819 in Healthy Subjects for Parkinson's Disease [Phase 1]
Phase I trial update for KM-819 in healthy subjects exploring Parkinson's disease treatment; study completed with results posted.
-
FDA approval · 2020-04-07FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's supplemental application for ropinirole, a generic version used to treat Parkinson's disease …
-
FDA approval · 2020-04-03FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc. This action typically reflects changes to labeling and/or…
-
FDA approval · 2020-04-03FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) submitted by Avvisto Therapeutics LLC.
-
FDA approval · 2020-04-02FDA Approved: ROPINIROLE — Supplemental Application (Marlex Pharmaceuticals Inc)
The FDA approved a supplemental application for ropinirole submitted by Marlex Pharmaceuticals Inc.
-
FDA approval · 2020-03-30FDA Approved: ENTACAPONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Entacapone from Aurobindo Pharma Limited, granting approval of a generic entacapone product as a…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Use of Low-dose Zolpidem in Parkinson's Disease [Phase 2]
Phase 2 trial update on low-dose zolpidem in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease [Phase 1, Phase 2]
Clinical trial update on CERE-120 for Parkinson's disease reports completed Phase 1/2 results with data posted in 2020.